Abstract
L-Arginine (L-arg) is metabolized to nitric oxide (NO) by inducible NO synthase (iNOS) or to urea and L-ornithine (L-orn) by arginase. NO is involved in the inflammatory response, whereas arginase is the first step in polyamine and proline synthesis necessary for tissue repair and wound healing. Mitogen-activated protein kinases (MAPK) mediate LPS-induced iNOS expression, and MAPK phosphatase-1 (MKP-1) plays a crucial role in limiting MAPK signaling in macrophages. We hypothesized that MKP-1, by attenuating iNOS expression, acts as a switch changing L-arg metabolism from NO production to L-orn production after endotoxin administration. To test this hypothesis, we performed studies in RAW264.7 macrophages stably transfected with an MKP-1 expression vector in thioglyollate-elicited peritoneal macrophages harvested from wild-type and Mkp-1(-/-) mice, as well as in vivo in wild-type and Mkp-1(-/-) mice. We found that overexpression of MKP-1 resulted in lower iNOS expression and NO production but greater urea production in response to LPS. Although deficiency of MKP-1 resulted in greater iNOS expression and NO production and lower urea production in response to LPS, neither the overexpression nor the deficiency of MKP-1 had any substantial effect on the expression of the arginases.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Animals
-
Arginase / genetics
-
Arginase / metabolism*
-
Arginine / metabolism*
-
Cell Cycle Proteins / genetics
-
Cell Cycle Proteins / metabolism*
-
Cell Line
-
Dual Specificity Phosphatase 1
-
Gene Expression Regulation, Enzymologic
-
Immediate-Early Proteins / deficiency
-
Immediate-Early Proteins / genetics
-
Immediate-Early Proteins / metabolism*
-
Inflammation / enzymology
-
Inflammation / genetics
-
Inflammation / metabolism*
-
JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
JNK Mitogen-Activated Protein Kinases / metabolism
-
Lipopolysaccharides / pharmacology*
-
Macrophages, Peritoneal / drug effects*
-
Macrophages, Peritoneal / enzymology
-
Macrophages, Peritoneal / metabolism
-
Mice
-
Mice, Knockout
-
Nitric Oxide / metabolism*
-
Nitric Oxide Synthase Type II / genetics
-
Nitric Oxide Synthase Type II / metabolism*
-
Ornithine / metabolism
-
Phosphoprotein Phosphatases / deficiency
-
Phosphoprotein Phosphatases / genetics
-
Phosphoprotein Phosphatases / metabolism*
-
Protein Kinase Inhibitors / pharmacology
-
Protein Phosphatase 1
-
Protein Tyrosine Phosphatases / deficiency
-
Protein Tyrosine Phosphatases / genetics
-
Protein Tyrosine Phosphatases / metabolism*
-
RNA, Messenger / metabolism
-
Time Factors
-
Transfection
-
Urea / metabolism
-
p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
p38 Mitogen-Activated Protein Kinases / metabolism
Substances
-
Cell Cycle Proteins
-
Immediate-Early Proteins
-
Lipopolysaccharides
-
Protein Kinase Inhibitors
-
RNA, Messenger
-
lipopolysaccharide, E coli O55-B5
-
Nitric Oxide
-
Urea
-
Arginine
-
Ornithine
-
Nitric Oxide Synthase Type II
-
Nos2 protein, mouse
-
JNK Mitogen-Activated Protein Kinases
-
p38 Mitogen-Activated Protein Kinases
-
Phosphoprotein Phosphatases
-
Protein Phosphatase 1
-
Dual Specificity Phosphatase 1
-
Dusp1 protein, mouse
-
Protein Tyrosine Phosphatases
-
Arg2 protein, mouse
-
Arginase